81_FR_24187 81 FR 24108 - Request for Public Comment: 60-Day Information Collection: Indian Self-Determination and Education Assistance Act Contracts

81 FR 24108 - Request for Public Comment: 60-Day Information Collection: Indian Self-Determination and Education Assistance Act Contracts

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service

Federal Register Volume 81, Issue 79 (April 25, 2016)

Page Range24108-24109
FR Document2016-09501

In compliance the Paperwork Reduction Act of 1995, the Indian Health Service (IHS) invites the general public to comment on the information collection titled, ``Indian Self-Determination and Education Assistance Act Contracts,'' Office of Management and Budget (OMB) Control Number 0917-0037. IHS is requesting OMB to approve an extension for this collection, which expires on July 31, 2016.

Federal Register, Volume 81 Issue 79 (Monday, April 25, 2016)
[Federal Register Volume 81, Number 79 (Monday, April 25, 2016)]
[Notices]
[Pages 24108-24109]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-09501]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Indian Health Service


Request for Public Comment: 60-Day Information Collection: Indian 
Self-Determination and Education Assistance Act Contracts

AGENCY: Indian Health Service, HHS.

ACTION: Notice and request for comments. Request for extension of 
approval.

-----------------------------------------------------------------------

SUMMARY: In compliance the Paperwork Reduction Act of 1995, the Indian 
Health Service (IHS) invites the general public to comment on the 
information collection titled, ``Indian Self-Determination and 
Education Assistance Act Contracts,'' Office of Management and Budget 
(OMB) Control Number 0917-0037. IHS is requesting OMB to approve an 
extension for this collection, which expires on July 31, 2016.

DATES: Comment Due Date: June 24, 2016. Your comments regarding this 
information collection are best assured of having full effect if 
received within 60 days of the date of this publication.

ADDRESSES: Send your written comments, requests for more information on 
the collection, or requests to obtain a copy of the data collection 
instrument and instructions to Mr. Chris Buchanan by one of the 
following methods:
     Mail: Mr. Chris Buchanan, Director, IHS Office of Direct 
Services and Contracting Tribes (ODSCT), Indian Health Service, 5600 
Fishers Lane, Mail Stop O8E17C, Rockville, MD 20857.
     Phone: 301-443-1104.
     Email: [email protected].
     Fax: 301-480-3192.

SUPPLEMENTARY INFORMATION: This previously approved information 
collection project was last published in the Federal Register (78 FR 
32405), as a joint submission with the Bureau of Indian Affairs (BIA), 
under OMB Control Number 1076-0136, on May 30, 2013 and allowed 30 days 
for public comment. No public comment was received in response to the 
notice. On July 31, 2013, the IHS obtained its own OMB Control Number, 
0917-0037, for this information collection and is now publishing a 
separate notice from the BIA in the Federal Register. The purpose of 
this notice is to allow 60 days for public comment. A copy of the 
supporting statement is available at www.regulations.gov (see Docket ID 
IHS-2016-0003).

[[Page 24109]]

I. Abstract

    Representatives of the IHS seek renewal of the approval for 
information collections conducted under 25 CFR part 900, implementing 
the Indian Self-Determination and Education Assistance Act (ISDEAA), as 
amended (25 U.S.C. 450 et seq.), which describes how contracts are 
awarded to Indian Tribes. The rule at 25 CFR part 900 was developed 
through negotiated rulemaking with Tribes in 1996 and governs, among 
other things, what must be included in a Tribe's initial ISDEAA 
contract proposal to IHS. A response is required to obtain and retain a 
benefit.
    The information requirements for this rule represent significant 
differences from other agencies in several respects. Under the Act, the 
Secretary of Health and Human Services is directed to enter into self-
determination contracts with Tribes upon request, unless specific 
declination criteria apply, and, generally, Tribes may renew these 
contracts annually, whereas other agencies provide grants on a 
discretionary or competitive basis. Additionally, IHS awards contracts 
for multiple programs whereas other agencies usually award single 
grants to Tribes.
    The IHS uses the information collected to determine applicant 
eligibility, evaluate applicant capabilities, protect the service 
population, safeguard Federal funds and other resources, and permit the 
Federal agency to administer and evaluate contract programs. Tribal 
governments or Tribal organizations provide the information by 
submitting contract proposals, and related information, to the IHS, as 
required under Public Law 93-638. No third party notification or public 
disclosure burden is associated with this collection.

II. Request for Comments

    The IHS requests your comments on this collection concerning: (a) 
The necessity of this information collection for the proper performance 
of the functions of the agency, including whether the information will 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden (hours and cost) of the collection of information, including 
the validity of the methodology and assumptions used; (c) ways we could 
enhance the quality, utility, and clarity of the information to be 
collected; and (d) ways we could minimize the burden of the collection 
of the information on the respondents.
    Please note that an agency may not conduct or sponsor, and an 
individual need not respond to, a collection of information unless it 
displays a valid OMB Control Number.
    It is our policy to make all comments available to the public for 
review at the location listed in the ADDRESSES section. Before 
including your address, phone number, email address or other personally 
identifiable information in your comment, you should be aware that your 
entire comment--including your personal identifying information--may be 
made publicly available at any time. While you can ask us in your 
comment to withhold your personal identifying information from public 
review, we cannot guarantee that we will be able to do so.

III. Data

    OMB Control Number: 0917-0037.
    Title: Indian Self-Determination and Education Assistance Act 
Contracts, 25 CFR part 900.
    Brief Description of Collection: An Indian Tribe or Tribal 
organization is required to submit this information each time that it 
proposes to contract with the IHS under the ISDEAA. Each response may 
vary in its length. In addition, each subpart of 25 CFR part 900 
concerns different parts of the contracting process. For example, 
subpart C relates to provisions of the contents for the initial 
contract proposal. The respondents do not incur the burden associated 
with subpart C when contracts are renewed. Subpart F describes minimum 
standards for management systems used by Indian Tribes or Tribal 
organizations under these contracts. Subpart G addresses the 
negotiability of all reporting and data requirements in the contracts. 
Responses are required to obtain or retain a benefit.
    Type of Review: Revision of currently approved collection.
    Respondents: Federally recognized Indian Tribes and Tribal 
organizations.
    Number of Respondents: 566.
    Estimated Number of Responses: 1510.
    Estimated Time per Response: Varies from 1 to 1040 hours, with an 
average of 15.968 hours per response.
    Frequency of Response: Each time programs, functions, services or 
activities are contracted from the IHS under the ISDEAA.
    Estimated Total Annual Hour Burden: 24,112.

    Dated: April 18, 2016.
Elizabeth A. Fowler,
Deputy Director For Management Operations, Indian Health Service.
[FR Doc. 2016-09501 Filed 4-22-16; 8:45 am]
 BILLING CODE 4165-16-P



                                                    24108                          Federal Register / Vol. 81, No. 79 / Monday, April 25, 2016 / Notices

                                                    chlorthalidone USP tablets, 15 mg, if all               failure, hepatic cirrhosis, and                       DEPARTMENT OF HEALTH AND
                                                    other legal and regulatory requirements                 corticosteroid and estrogen therapy.                  HUMAN SERVICES
                                                    are met.                                                Chlorthalidone has also been found
                                                    FOR FURTHER INFORMATION CONTACT:                        useful in edema due to various forms of               Indian Health Service
                                                    Christopher Koepke, Center for Drug                     renal dysfunction such as nephrotic
                                                                                                            syndrome, acute glomerulonephritis,                   Request for Public Comment: 60-Day
                                                    Evaluation and Research, Food and
                                                                                                            and chronic renal failure.                            Information Collection: Indian Self-
                                                    Drug Administration, 10903 New
                                                                                                               THALITONE (chlorthalidone USP)                     Determination and Education
                                                    Hampshire Ave., Bldg. 51, Rm. 6214,
                                                                                                            tablets, 15 mg, are currently listed in the           Assistance Act Contracts
                                                    Silver Spring, MD 20993–0002, 240–
                                                    402–3543.                                               ‘‘Discontinued Drug Product List’’
                                                                                                            section of the Orange Book.                           AGENCY: Indian Health Service, HHS.
                                                    SUPPLEMENTARY INFORMATION: In 1984,
                                                                                                               Clinipace Worldwide submitted a                    ACTION:Notice and request for
                                                    Congress enacted the Drug Price                         citizen petition dated September 9, 2015              comments. Request for extension of
                                                    Competition and Patent Term                             (Docket No. FDA–2015–P–3299), under                   approval.
                                                    Restoration Act of 1984 (Pub. L. 98–417)                21 CFR 10.30, requesting that the
                                                    (the 1984 amendments), which                            Agency determine whether                              SUMMARY:   In compliance the Paperwork
                                                    authorized the approval of duplicate                    THALITONE (chlorthalidone USP)                        Reduction Act of 1995, the Indian
                                                    versions of drug products under an                      tablets, 15 mg, were withdrawn from                   Health Service (IHS) invites the general
                                                    ANDA procedure. ANDA applicants                         sale for reasons of safety or                         public to comment on the information
                                                    must, with certain exceptions, show that                effectiveness.                                        collection titled, ‘‘Indian Self-
                                                    the drug for which they are seeking                        After considering the citizen petition             Determination and Education
                                                    approval contains the same active                       and reviewing Agency records and                      Assistance Act Contracts,’’ Office of
                                                    ingredient in the same strength and                     based on the information, FDA has                     Management and Budget (OMB) Control
                                                    dosage form as the ‘‘listed drug,’’ which               determined under § 314.161 that                       Number 0917–0037. IHS is requesting
                                                    is a version of the drug that was                       THALITONE (chlorthalidone USP)                        OMB to approve an extension for this
                                                    previously approved. ANDA applicants                    tablets, 15 mg, were not withdrawn for                collection, which expires on July 31,
                                                    do not have to repeat the extensive                     reasons of safety or effectiveness. The               2016.
                                                    clinical testing otherwise necessary to                 petitioner has identified no data or other
                                                    gain approval of a new drug application                                                                       DATES:  Comment Due Date: June 24,
                                                                                                            information suggesting that
                                                    (NDA).                                                                                                        2016. Your comments regarding this
                                                                                                            THALITONE (chlorthalidone USP)
                                                       The 1984 amendments include what                                                                           information collection are best assured
                                                                                                            tablets, 15 mg, were withdrawn for
                                                    is now section 505(j)(7) of the Federal                                                                       of having full effect if received within
                                                                                                            reasons of safety or effectiveness. We
                                                    Food, Drug, and Cosmetic Act (21 U.S.C.                                                                       60 days of the date of this publication.
                                                                                                            have carefully reviewed our files for
                                                    355(j)(7)), which requires FDA to                       records concerning the withdrawal of                  ADDRESSES: Send your written
                                                    publish a list of all approved drugs.                   THALITONE (chlorthalidone USP)                        comments, requests for more
                                                    FDA publishes this list as part of the                  tablets, 15 mg, from sale. We have also               information on the collection, or
                                                    ‘‘Approved Drug Products With                           independently evaluated relevant                      requests to obtain a copy of the data
                                                    Therapeutic Equivalence Evaluations,’’                  literature and data for possible                      collection instrument and instructions
                                                    which is known generally as the                         postmarketing adverse events. We have                 to Mr. Chris Buchanan by one of the
                                                    ‘‘Orange Book.’’ Under FDA regulations,                 reviewed the available evidence and                   following methods:
                                                    drugs are removed from the list if the                  determined that this drug product was                    • Mail: Mr. Chris Buchanan, Director,
                                                    Agency withdraws or suspends                            not withdrawn from sale for reasons of                IHS Office of Direct Services and
                                                    approval of the drug’s NDA or ANDA                      safety or effectiveness.                              Contracting Tribes (ODSCT), Indian
                                                    for reasons of safety or effectiveness or                  Accordingly, the Agency will                       Health Service, 5600 Fishers Lane, Mail
                                                    if FDA determines that the listed drug                  continue to list THALITONE                            Stop O8E17C, Rockville, MD 20857.
                                                    was withdrawn from sale for reasons of                  (chlorthalidone USP) tablets, 15 mg, in                  • Phone: 301–443–1104.
                                                    safety or effectiveness (21 CFR 314.162).               the ‘‘Discontinued Drug Product List’’                   • Email: Chris.Buchanan@ihs.gov.
                                                       A person may petition the Agency to                  section of the Orange Book. The
                                                    determine, or the Agency may                                                                                     • Fax: 301–480–3192.
                                                                                                            ‘‘Discontinued Drug Product List’’
                                                    determine on its own initiative, whether                delineates, among other items, drug                   SUPPLEMENTARY INFORMATION: This
                                                    a listed drug was withdrawn from sale                   products that have been discontinued                  previously approved information
                                                    for reasons of safety or effectiveness.                 from marketing for reasons other than                 collection project was last published in
                                                    This determination may be made at any                   safety or effectiveness. ANDAs that refer             the Federal Register (78 FR 32405), as
                                                    time after the drug has been withdrawn                  to THALITONE (chlorthalidone USP)                     a joint submission with the Bureau of
                                                    from sale, but must be made prior to                    tablets, 15 mg, may be approved by the                Indian Affairs (BIA), under OMB
                                                    approving an ANDA that refers to the                    Agency as long as they meet all other                 Control Number 1076–0136, on May 30,
                                                    listed drug (§ 314.161 (21 CFR 314.161)).               legal and regulatory requirements for                 2013 and allowed 30 days for public
                                                    FDA may not approve an ANDA that                        the approval of ANDAs. If FDA                         comment. No public comment was
                                                    does not refer to a listed drug.                        determines that labeling for this drug                received in response to the notice. On
                                                       THALITONE (chlorthalidone USP)                       product should be revised to meet                     July 31, 2013, the IHS obtained its own
                                                    tablets, 15 mg, are the subject of NDA                                                                        OMB Control Number, 0917–0037, for
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                                                                            current standards, the Agency will
                                                    19–574, held by Citron Pharma LLC,                      advise ANDA applicants to submit such                 this information collection and is now
                                                    and initially approved on December 20,                  labeling.                                             publishing a separate notice from the
                                                    1988. THALITONE is indicated for the                                                                          BIA in the Federal Register. The
                                                    management of hypertension either                         Dated: April 19, 2016.                              purpose of this notice is to allow 60
                                                    alone or in combination with other                      Leslie Kux,                                           days for public comment. A copy of the
                                                    antihypertensive drugs. Chlorthalidone                  Associate Commissioner for Policy.                    supporting statement is available at
                                                    is indicated as an adjunctive therapy in                [FR Doc. 2016–09450 Filed 4–22–16; 8:45 am]           www.regulations.gov (see Docket ID
                                                    edema associated with congestive heart                  BILLING CODE 4164–01–P                                IHS–2016–0003).


                                               VerDate Sep<11>2014   19:02 Apr 22, 2016   Jkt 238001   PO 00000   Frm 00057   Fmt 4703   Sfmt 4703   E:\FR\FM\25APN1.SGM   25APN1


                                                                                   Federal Register / Vol. 81, No. 79 / Monday, April 25, 2016 / Notices                                                24109

                                                    I. Abstract                                             information unless it displays a valid                DEPARTMENT OF HEALTH AND
                                                       Representatives of the IHS seek                      OMB Control Number.                                   HUMAN SERVICES
                                                    renewal of the approval for information                   It is our policy to make all comments
                                                                                                            available to the public for review at the             National Institutes of Health
                                                    collections conducted under 25 CFR
                                                    part 900, implementing the Indian Self-                 location listed in the ADDRESSES section.
                                                                                                            Before including your address, phone                  Office of the Director, National
                                                    Determination and Education                                                                                   Institutes of Health Notice of Meeting
                                                    Assistance Act (ISDEAA), as amended                     number, email address or other
                                                    (25 U.S.C. 450 et seq.), which describes                personally identifiable information in                   Pursuant to section 10(a) of the
                                                    how contracts are awarded to Indian                     your comment, you should be aware                     Federal Advisory Committee Act, as
                                                    Tribes. The rule at 25 CFR part 900 was                 that your entire comment—including                    amended (5 U.S.C. App.), notice is
                                                    developed through negotiated                            your personal identifying information—                hereby given of a meeting of the
                                                    rulemaking with Tribes in 1996 and                      may be made publicly available at any                 Advisory Committee to the Director,
                                                    governs, among other things, what must                  time. While you can ask us in your                    National Institutes of Health.
                                                    be included in a Tribe’s initial ISDEAA                 comment to withhold your personal                        The meeting will be open to the
                                                    contract proposal to IHS. A response is                 identifying information from public                   public, with attendance limited to space
                                                    required to obtain and retain a benefit.                review, we cannot guarantee that we                   available. Individuals who plan to
                                                       The information requirements for this                will be able to do so.                                attend and need special assistance, such
                                                    rule represent significant differences                  III. Data                                             as sign language interpretation or other
                                                    from other agencies in several respects.                                                                      reasonable accommodations, should
                                                    Under the Act, the Secretary of Health                    OMB Control Number: 0917–0037.
                                                                                                                                                                  notify the Contact Person listed below
                                                    and Human Services is directed to enter                   Title: Indian Self-Determination and                in advance of the meeting.
                                                    into self-determination contracts with                  Education Assistance Act Contracts, 25
                                                                                                            CFR part 900.                                            Name of Committee: Advisory Committee
                                                    Tribes upon request, unless specific                                                                          to the Director, National Institutes of Health.
                                                    declination criteria apply, and,                          Brief Description of Collection: An                    Date:June 9–10, 2016.
                                                    generally, Tribes may renew these                       Indian Tribe or Tribal organization is                   Time: June 09, 2016, 9:00 a.m. to 5:00 p.m.
                                                    contracts annually, whereas other                       required to submit this information each                 Agenda: NIH Director’s Report, ACD
                                                    agencies provide grants on a                            time that it proposes to contract with                Working Group reports.
                                                    discretionary or competitive basis.                     the IHS under the ISDEAA. Each                           Place: National Institutes of Health
                                                    Additionally, IHS awards contracts for                  response may vary in its length. In                   Building 31, 6th Floor Conference Room 6C6,
                                                    multiple programs whereas other                         addition, each subpart of 25 CFR part                 31 Center Drive, Bethesda, MD 20892.
                                                                                                            900 concerns different parts of the                      Time: June 10, 2016, 9:00 a.m. to
                                                    agencies usually award single grants to                                                                       adjournment
                                                    Tribes.                                                 contracting process. For example,
                                                                                                                                                                     Agenda: IC Director Report and other
                                                       The IHS uses the information                         subpart C relates to provisions of the                business of the committee.
                                                    collected to determine applicant                        contents for the initial contract                        Place: National Institutes of Health,
                                                    eligibility, evaluate applicant                         proposal. The respondents do not incur                Building 31, 6th Floor Conference Room 6C6,
                                                    capabilities, protect the service                       the burden associated with subpart C                  31 Center Drive, Bethesda, MD 20892.
                                                    population, safeguard Federal funds and                 when contracts are renewed. Subpart F                    Contact Person: Gretchen Wood, Staff
                                                    other resources, and permit the Federal                 describes minimum standards for                       Assistant, National Institutes of Health,
                                                    agency to administer and evaluate                       management systems used by Indian                     Office of the Director, One Center Drive,
                                                                                                            Tribes or Tribal organizations under                  Building 1, Room 126, Bethesda, MD
                                                    contract programs. Tribal governments
                                                                                                            these contracts. Subpart G addresses the              20892,301–496–4272, woodgs@od.nih.gov.
                                                    or Tribal organizations provide the
                                                                                                            negotiability of all reporting and data                  Any interested person may file written
                                                    information by submitting contract
                                                                                                            requirements in the contracts.                        comments with the committee by forwarding
                                                    proposals, and related information, to                                                                        the statement to the Contact Person listed on
                                                    the IHS, as required under Public Law                   Responses are required to obtain or                   this notice. The statement should include the
                                                    93–638. No third party notification or                  retain a benefit.                                     name, address, telephone number and when
                                                    public disclosure burden is associated                    Type of Review: Revision of currently               applicable, the business or professional
                                                    with this collection.                                   approved collection.                                  affiliation of the interested person.
                                                                                                              Respondents: Federally recognized                      In the interest of security, NIH has
                                                    II. Request for Comments                                                                                      instituted stringent procedures for entrance
                                                                                                            Indian Tribes and Tribal organizations.
                                                       The IHS requests your comments on                      Number of Respondents: 566.                         onto the NIH campus. All visitor vehicles,
                                                    this collection concerning: (a) The                                                                           including taxicabs, hotel, and airport shuttles
                                                                                                              Estimated Number of Responses:                      will be inspected before being allowed on
                                                    necessity of this information collection                1510.                                                 campus. Visitors will be asked to show one
                                                    for the proper performance of the                         Estimated Time per Response: Varies                 form of identification (for example, a
                                                    functions of the agency, including                      from 1 to 1040 hours, with an average                 government-issued photo ID, driver’s license,
                                                    whether the information will have                       of 15.968 hours per response.                         or passport) and to state the purpose of their
                                                    practical utility; (b) the accuracy of the                Frequency of Response: Each time                    visit.
                                                    agency’s estimate of the burden (hours                  programs, functions, services or                         Information is also available on the
                                                    and cost) of the collection of                                                                                Institute’s/Center’s home page:http://
                                                                                                            activities are contracted from the IHS
                                                    information, including the validity of                                                                        acd.od.nih.gov, where an agenda and any
                                                                                                            under the ISDEAA.                                     additional information for the meeting will
                                                    the methodology and assumptions used;
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                                                                              Estimated Total Annual Hour Burden:                 be posted when available.
                                                    (c) ways we could enhance the quality,                  24,112.
                                                    utility, and clarity of the information to                                                                    (Catalogue of Federal Domestic Assistance
                                                                                                              Dated: April 18, 2016.                              Program Nos. 93.14, Intramural Research
                                                    be collected; and (d) ways we could
                                                                                                            Elizabeth A. Fowler,                                  Training Award; 93.22, Clinical Research
                                                    minimize the burden of the collection of                                                                      Loan Repayment Program for Individuals
                                                    the information on the respondents.                     Deputy Director For Management Operations,
                                                                                                                                                                  from Disadvantaged Backgrounds; 93.232,
                                                       Please note that an agency may not                   Indian Health Service.
                                                                                                                                                                  Loan Repayment Program for Research
                                                    conduct or sponsor, and an individual                   [FR Doc. 2016–09501 Filed 4–22–16; 8:45 am]           Generally; 93.39, Academic Research
                                                    need not respond to, a collection of                    BILLING CODE 4165–16–P                                Enhancement Award; 93.936, NIH Acquired



                                               VerDate Sep<11>2014   19:02 Apr 22, 2016   Jkt 238001   PO 00000   Frm 00058   Fmt 4703   Sfmt 4703   E:\FR\FM\25APN1.SGM   25APN1



Document Created: 2016-04-23 01:39:21
Document Modified: 2016-04-23 01:39:21
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice and request for comments. Request for extension of approval.
FR Citation81 FR 24108 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR